Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01208103
Title Bevacizumab With Capecitabine and Oxaliplatin in Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

small intestine adenocarcinoma

ampulla of Vater adenocarcinoma


Bevacizumab + Capecitabine + Oxaliplatin

Age Groups: adult
Covered Countries USA

No variant requirements are available.